NIKKEI 225
27,469.09 -7.78 (-0.03%) HANG SENG
19,662.50 +94.81 (+0.48%) CRUDE OIL
72.81 0.00 (0.00%) GOLD FUTURES
1,961.40 +7.60 (+0.39%) DOW
32,432.08 +194.55 (+0.60%) BTC-GBP
21,912.06 -755.25 (-3.33%)
Bionano Genomics, Inc. (BNGO)
After hours:
- Motley Fool
Buy This Magnificent Growth Stock Before It's Too Late
Bionano Genomics (NASDAQ: BNGO) appears to be in just that place -- at the start of its growth journey -- and it could be a great way to give your portfolio some additional upside potential. Bionano's claim to fame is its laboratory analyzer device for optical genome mapping, which it calls the Saphyr.
- Motley Fool
Bionano Genomics (BNGO) Q4 2022 Earnings Call Transcript
Image source: The Motley Fool. Bionano Genomics (NASDAQ: BNGO)Q4 2022 Earnings CallMar 09, 2023, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day and welcome to the Bionano fourth-quarter and full-year 2022 earnings conference call.
- Zacks
Bionano Genomics, Inc. (BNGO) Reports Q4 Loss, Misses Revenue Estimates
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -44.44% and 0.32%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
